Latin America Regulatory Round-Up: A Red Tape Reduction In Brazil, Mexico
Executive Summary
A recap of the latest Rx regulatory developments this summer (or winter) from Latin America regulators.
You may also be interested in...
Brazil Tightens Outsourcing Restrictions Just Months After Easing Them
ANVISA's new resolution requires that companies importing finished drug products have their own quality control laboratory and warehouse.
Brazil's Backlog Is Nearly Clear, But Convergence Still A Work In Progress
Drug application backlog has been distraction for agency and prevents focus on other projects, says ANVISA General Manager of Drugs Raphael Sanches Pereira.
Brazil's Product Licensing Restrictions Eventually May Get Easier
Brazilian drug regulator Anvisa has made some changes over the years, but still restricts companies with approved Rx products from licensing them to another company.